Molybdenum
What it is · too little · too much · daily reference values by country
For reference only. This is not a diagnosis or a prescription. If you have concerns, talk to a doctor or pharmacist.
What it is
- Molybdenum acts as a cofactor that helps body enzymes such as xanthine oxidase do their work, and it takes part in the making of uric acid. (Korea Ministry of Health and Welfare · Korean Nutrition Society)
- Molybdenum is required as an essential component of several enzymes involved in oxidation-reduction reactions and transfer of electrons. (European Food Safety Authority)
Getting too little
- No cases of molybdenum deficiency have been reported in healthy people, but a case was reported in one patient who received long-term total parenteral nutrition through a central vein. (Korea Ministry of Health and Welfare · Korean Nutrition Society)
- Molybdenum deficiency in healthy humans has not been observed. (European Food Safety Authority)
Getting too much
- There are almost no human studies on molybdenum toxicity, but joint pain, high uric acid in the urine, and gout-like symptoms were seen in some residents of certain areas of Armenia where the soil is high in molybdenum. (Korea Ministry of Health and Welfare · Korean Nutrition Society)
Daily reference values by country
Korea · US · EU — tap to open
These tables are daily reference values for healthy people. Numbers in the text above are a different kind of value, and you cannot diagnose yourself from them. How to read RDA, AI and UL
Korea — 2025 Dietary Reference Intakes for Koreans (Ministry of Health and Welfare)
| Group | EAR | RNI | UL |
|---|---|---|---|
| 1–2 years | 8 μg | 10 μg | Checking |
| 3–5 years | 10 μg | 13 μg | Checking |
| Male · 6–8 years | 15 μg | 20 μg | Checking |
| Male · 9–11 years | 20 μg | 25 μg | Checking |
| Male · 12–14 years | 25 μg | 30 μg | Checking |
| Male · 15–18 years | 30 μg | 40 μg | Checking |
| Male · 19–29 years | 25 μg | 30 μg | Checking |
| Male · 30–49 years | 25 μg | 30 μg | Checking |
| Male · 50–64 years | 25 μg | 30 μg | Checking |
| Male · 65–74 years | 25 μg | 30 μg | Checking |
| Male · 75+ years | 20 μg | 25 μg | Checking |
| Female · 6–8 years | 15 μg | 20 μg | Checking |
| Female · 9–11 years | 15 μg | 20 μg | Checking |
| Female · 12–14 years | 20 μg | 25 μg | Checking |
| Female · 15–18 years | 20 μg | 25 μg | Checking |
| Female · 19–29 years | 20 μg | 25 μg | Checking |
| Female · 30–49 years | 20 μg | 25 μg | Checking |
| Female · 50–64 years | 20 μg | 25 μg | Checking |
| Female · 65–74 years | 20 μg | 25 μg | Checking |
| Female · 75+ years | 15 μg | 20 μg | Checking |
| Pregnancy | +0 μg | +0 μg | Checking |
| Lactation | +3 μg | +5 μg | Checking |
US — NASEM (National Academies)
| Group | EAR | RDA | AI | UL |
|---|---|---|---|---|
| 1–3 years | 13 μg | 17 μg | 300 μg | |
| 4–8 years | 17 μg | 22 μg | 600 μg | |
| Male · 9–13 years | 26 μg | 34 μg | 1100 μg | |
| Male · 14–18 years | 33 μg | 43 μg | 1700 μg | |
| Male · 19–30 years | 34 μg | 45 μg | 2000 μg | |
| Male · 31–50 years | 34 μg | 45 μg | 2000 μg | |
| Male · 51–70 years | 34 μg | 45 μg | 2000 μg | |
| Male · 71+ years | 34 μg | 45 μg | 2000 μg | |
| Female · 9–13 years | 26 μg | 34 μg | 1100 μg | |
| Female · 14–18 years | 33 μg | 43 μg | 1700 μg | |
| Female · 19–30 years | 34 μg | 45 μg | 2000 μg | |
| Female · 31–50 years | 34 μg | 45 μg | 2000 μg | |
| Female · 51–70 years | 34 μg | 45 μg | 2000 μg | |
| Female · 71+ years | 34 μg | 45 μg | 2000 μg | |
| Pregnancy · 14–18 years | 40 μg | 50 μg | 1700 μg | |
| Pregnancy · 19–30 years | 40 μg | 50 μg | 2000 μg | |
| Pregnancy · 31–50 years | 40 μg | 50 μg | 2000 μg | |
| Lactation · 14–18 years | 35 μg | 50 μg | 1700 μg | |
| Lactation · 19–30 years | 36 μg | 50 μg | 2000 μg | |
| Lactation · 31–50 years | 36 μg | 50 μg | 2000 μg | |
| 0–6 months | 2 μg | — | ||
| 7–12 months | 3 μg | — |
- UL — applies to: Unless otherwise specified, the UL represents total intake from food, water, and supplements.
EU — EFSA (European Food Safety Authority)
| Group | AI | UL |
|---|---|---|
| 7–11 months | 10 μg | |
| 1–3 years | 15 μg | 100 μg |
| 4–6 years | 20 μg | 200 μg |
| 7–10 years | 30 μg | 250 μg |
| 11–14 years | 45 μg | 400 μg |
| 15–17 years | 65 μg | 500 μg |
| 18+ years | 65 μg | 600 μg |
| Pregnancy · 18–60 years | 65 μg | |
| Lactation · 18–60 years | 65 μg | |
| Pregnancy · 18+ years | 600 μg | |
| Lactation · 18+ years | 600 μg |
- UL — applies to: Total chronic daily intake from all dietary sources.
Sources
- EFSA DRV Finder (Dietary Reference Values) · checked 2026-10-07
- EFSA DRV Finder — nutrient descriptions · checked 2026-10-07
- EFSA Overview on Tolerable Upper Intake Levels (v11, August 2025) · checked 2026-10-07
- 2025 Dietary Reference Intakes for Koreans, Vol. 3: Minerals (Korean Ministry of Health and Welfare · The Korean Nutrition Society; in Korean) · checked 2026-10-07
- 2025 Dietary Reference Intakes for Koreans — summary tables (Korean Ministry of Health and Welfare · The Korean Nutrition Society; in Korean) · checked 2026-10-07
- NASEM Dietary Reference Intakes summary tables (Appendix J, 2019) · checked 2026-10-07
The sentences are plain-language summaries of official sources written by SuppleBoard. Each English sentence was checked against the source text by an AI reviewer before publishing. The agencies do not endorse this site. Published 2026-10-17.